CompanyScope

Bristol-Myers Squibb Company income statement & cash flow

Tickers BMY, CELG-RI · SEC CIK 14272 · Latest fiscal year ended Dec 31, 2025

In the fiscal year ended Dec 31, 2025, Bristol-Myers Squibb Company reported net income of $7.05B on revenue of $48.19B. Operating cash flow was $14.16B and capital expenditures were $1.31B, leaving $12.85B of free cash flow (operating cash flow minus capital expenditures).

−$10B−$5B$0$5B$10BDec 2016: $4.46BDec 2017: $1.01BDec 2018: $4.92BDec 2019: $3.44BDec 2020: −$9.02BDec 2021: $6.99BDec 2022: $6.33BDec 2023: $8.03BDec 2024: −$8.95BDec 2025: $7.05BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Bristol-Myers Squibb Company net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year endedDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue (USD)$19.43B$20.78B$22.56B$26.14B$42.52B$46.38B$46.16B$45.01B$48.30B$48.19B
Gross profit (USD)$14.48B$14.68B$16.09B$18.07B$30.75B—————
Net income (USD)$4.46B$1.01B$4.92B$3.44B−$9.02B$6.99B$6.33B$8.03B−$8.95B$7.05B
Diluted EPS (USD per share)$2.65$0.61$3.01$2.01−$3.99$3.12$2.95$3.86−$4.41$3.46
Operating cash flow (USD)$3.06B$5.28B$7.07B$8.21B$14.05B$16.21B$13.07B$13.86B$15.19B$14.16B
Capital expenditures (USD)$1.22B$1.05B$951.00M$836.00M$753.00M$973.00M$1.12B$1.21B$1.25B$1.31B
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202410-K 202510-K 202610-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year endedGross marginOperating marginNet margin
Dec 2025——14.6%
Dec 2024——-18.5%
Dec 2023——17.8%
Dec 2022——13.7%
Dec 2021——15.1%
$0$5B$10B$15B$20BDec 2016: $3.06BDec 2017: $5.28BDec 2018: $7.07BDec 2019: $8.21BDec 2020: $14.05BDec 2021: $16.21BDec 2022: $13.07BDec 2023: $13.86BDec 2024: $15.19BDec 2025: $14.16BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Bristol-Myers Squibb Company operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 14272 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.